Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma With Portal Vein Tumor Thrombus”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Not applicableUnknownNCT05491889
What this trial is testing

Outcome of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis After Trans-Arterial Chemo Embolization

Who this might be right for
Hepatocellular Carcinoma
Assiut University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Testing effectiveness (Phase 2)UnknownNCT02452853
What this trial is testing

HR Combined With FOLFOX4 for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 51
Testing effectiveness (Phase 2)UnknownNCT04850157
What this trial is testing

Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05625893
What this trial is testing

Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Samsung Medical Center 63
Testing effectiveness (Phase 2)Looking for participantsNCT06664996
What this trial is testing

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 33
Testing effectiveness (Phase 2)UnknownNCT03520257
What this trial is testing

The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 50
Testing effectiveness (Phase 2)UnknownNCT04135690
What this trial is testing

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 60
Not applicableEnded earlyNCT01690715
What this trial is testing

Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery

Who this might be right for
Hepatocellular CarcinomaPortal Vein ThrombosisHepatic Portal Vein Tumor Invasion
Hospital Sirio-Libanes 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363512
What this trial is testing

Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 27
Not applicableLooking for participantsNCT05984511
What this trial is testing

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular CarcinomaHepatic Portal Vein Tumor InvasionTumor Thrombus
Third Affiliated Hospital, Sun Yat-Sen University 234
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Testing effectiveness (Phase 2)Ended earlyNCT03035006
What this trial is testing

Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Tumor Thrombosis
Taiwan Liposome Company 1
Not applicableStudy completedNCT05040347
What this trial is testing

Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular Carcinoma

Who this might be right for
Neutrophil Extracellular Trap FormationPortal Vein Tumor Thrombosis
The Affiliated Hospital of Qingdao University 68
Testing effectiveness (Phase 2)Looking for participantsNCT06031285
What this trial is testing

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 43
Not applicableUnknownNCT06061445
What this trial is testing

Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma

Who this might be right for
Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital 22
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Testing effectiveness (Phase 2)Looking for participantsNCT06349317
What this trial is testing

Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Yongyi Zeng 33
Testing effectiveness (Phase 2)Study completedNCT01850368
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Korea Cancer Center Hospital 35
Testing effectiveness (Phase 2)UnknownNCT05872841
What this trial is testing

H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis

Who this might be right for
Primary Hepatocellular CarcinomaPortal Vein Thrombosis
Tianjin Medical University Cancer Institute and Hospital 38
Load More Results